Bayer AG MTN v.2023(2033/2033)

Type of financial instrument

Corporate Bond

Sub-Type

Health Care

Yield

3.88

Yield spread Bundesanleihe

1.0601

Tradable for private investors

Yes

Minimum amount tradeable unit

1,000.00

Maturity

26/05/2033

Interest Rate

4.625 %

Currency

Euro

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE / YIELD104.536 G / 3.880 Units
PRICE DETERMINATION TIME06/12/2026 / 09:47:48 PM
DAILY VOLUME (NOMINAL)78,000
YIELD SPREAD1.0601
FIXINGPRICE-
DAILY HIGH / LOW104.786104.304
PREV. DAY'S PRICE104.28 (06/11)
CHANGE DAY BEFORE
+0.26
0.25 %
52 WEEK HIGH / LOW107.86 (08/05)102.825 (03/27)

Master Data

WKN
A351U1
ISIN
XS2630111719
SYMBOL
-
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Corporate Bond
SUB-TYPEHealth Care
ISSUER
Bayer AG
S&P RATINGPlease log in to view this field
(TRADING) SEGMENT / TICKS
-/ -
TRADING HOURS
07:30:00 AM - 10:00:00 PM
INTEREST RATE
4.625 %
INTEREST RUN FROM
26/05/2023
NEXT INTEREST PAYMENT
26/05/2027
UNIT INTEREST FROM NOMINAL AMMOUNT
0.266 %
TRADING CURRENCY / NOTATION
Euro/ Percent
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
QUOTATION
Continuous trading
ISSUING VOLUME
1.50 Bil.
MINIMUM AMOUNT TRADEABLE UNIT
1,000.00
SMALLEST TRADEABLE UNIT
1,000.00
MATURITY
26/05/2033
MARKET MAKER
-
STEP UP/ DOWN WHEN RATING CHANGES
No
STEP UP FIXED AT ISSUE
No
STEP DOWN FIXED AT ISSUE
No
BOND CALLABLE BY THE ISSUER
Yes
BOND IS SUBORDINATED
No

Description

Callable bond.

Tradability Information

Please log in to see the tradability information for this stock.

Not registered yet? Create an account here.

Company profile

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.